Novavax’s $1.4 Billion Licensing Agreement with Sanofi

Ropes & Gray represented Novavax Inc. in the transaction.Novavax Inc.(Nasdaq: NVAX) announced it has entered into a co-exclusive licensing agreement with French pharmaceutical company Sanofi to…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now